A case of juvenile Canavan disease with distinct pons involvement

Nafiye Emel Çakar1, Tuğçe Aksu Uzunhan2

  • 1University of Health Sciences, Okmeydanı Training and Research Hospital, Division of Paediatric Metabolism, Turkey.

Brain & Development
|December 17, 2019
PubMed

Insights

Juvenile Canavan disease, a rare leukodystrophy, can present with tremor and basal ganglia involvement, not just white matter changes. This case highlights a unique presentation in a 13-year-old with a specific genetic mutation.

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases
  • Leukodystrophies

Background:

  • Canavan disease is a rare genetic neurodegenerative disorder affecting white matter.
  • It typically presents in infancy with developmental delay, macrocephaly, and visual issues.
  • Congenital and juvenile forms are also recognized.

Observation:

  • A 13-year-old male diagnosed with juvenile Canavan disease presented with intentional tremor as the sole clinical symptom.
  • This contrasts with typical infantile presentations.

Findings:

  • MRI revealed significant involvement of the caudate nucleus and pons, extending to the mesencephalon, putamen, and thalamus.
  • Notably, there was no apparent signal alteration in the cerebral white matter.
  • A homozygous p.Gly274Arg (c.820A>G) missense mutation was identified.

Implications:

  • This case describes a previously unreported presentation of juvenile Canavan disease with predominant pons and basal ganglia involvement.
  • It suggests that juvenile Canavan disease may manifest with atypical neuroimaging findings, emphasizing the need for genetic testing in suspected cases.
  • Understanding these rare forms expands diagnostic criteria and informs potential therapeutic strategies for leukodystrophies.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
670
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
521
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K